Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Table of Contents

July 01, 2011; Volume 78,Issue 7

From the Editor

  • You have access
    When good drugs turn weirdly bad
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 426; DOI: https://doi.org/10.3949/ccjm.78b.11007

    Even the most specific of drugs, such as interferon, can have untoward biologic effects.

Medical Grand Rounds

  • You have access
    Update in hospital medicine: Studies likely to affect inpatient practice in 2011
    Amir K. Jaffer, MD
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 430-434; DOI: https://doi.org/10.3949/ccjm.78gr.11002

    A hypothetical case scenario helps focus on anticoagulants, patient safety, quality improvement, critical care, transitions of care, and perioperative medicine.

Review

  • You have access
    Hypothermia after cardiac arrest: Beneficial, but slow to be adopted
    Santosh Samuel Oommen, MD and Venu Menon, MD
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157

    Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.

Cancer Diagnosis and Management

  • You have access
    Managing cancer pain: Frequently asked questions
    Raghava R. Induru, MD and Ruth L. Lagman, MD, MPH, FACP
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 449-464; DOI: https://doi.org/10.3949/ccjm.78a.10054

    Cancer pain: its pathogenesis, how to assess it, and how to treat it—in particular, how to use opioids optimally.

Current Drug Therapy

  • You have access
    Vancomycin: A 50-something-yearold antibiotic we still don’t understand
    Amy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MD
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168

    To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.

The Clinical Picture

  • You have access
    Rash from hepatitis C treatment
    Derek M. Tang, MD and Lawrence Ward, MD, MPH
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124

    Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.

Editorial

  • You have access
    Bronchial thermoplasty: A promising therapy, still in its infancy
    Amit K. Mahajan, MD and D. Kyle Hogarth, MD, FCCP
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 475-476; DOI: https://doi.org/10.3949/ccjm.78a.11063

    Inflammation is not the only pathophysiologic process underlying asthma. Bronchial thermoplasty takes a novel approach and offers reason for optimism.

Review

  • Bronchial thermoplasty: A new treatment for severe refractory asthma
    You have access
    Bronchial thermoplasty: A new treatment for severe refractory asthma
    Thomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPH
    Cleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185

    Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 78 (7)
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 7
1 Jul 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • Medical Grand Rounds
  • Review
  • Cancer Diagnosis and Management
  • Current Drug Therapy
  • The Clinical Picture
  • Editorial
  • Review
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
The beat goes on: Highlights from the new American and European A-fib guidelines
What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Tinea incognito
Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Sarcoidosis with diffuse purplish erythematous plaques on the hands
Cardiovascular disease in people living with HIV: Risk assessment and management
Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Don’t judge a book by its cover: Unusual presentations of pericardial disease
Hypoglycemia after bariatric surgery: Management updates
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Common electrolyte imbalance, uncommon cause

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire